Exazyme: Funding, Investors & Team (Sep 2026)
Exazyme allows you to optimize proteins more quickly, efficiently, and effectively. Our AI-powered system ensures that you spend less time in the lab while still getting the best results.
Exazyme has raised $2.2M across 1 funding round on record, the most recent a Seed of $2.2M announced in May 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Exazyme Company Profile and Key Stats
Latest funding round on record: May 2023.
Exazyme Funding Rounds
Exazyme Founders and Leadership Team
Contact details for the Exazyme team: 1 of 1 has an email address on file.
Start 14-day free trial →Exazyme Funding Compared to Other Biotechnology Startups
Exazyme's latest round of $2.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Exazyme in Biotechnology and Berlin
Companies Similar to Exazyme
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Exazyme Funding FAQs
What does Exazyme do?
Exazyme allows you to optimize proteins more quickly, efficiently, and effectively. Our AI-powered system ensures that you spend less time in the lab while still getting the best results.
How much funding has Exazyme raised?
Exazyme has raised $2.2M across 1 round on record. The most recent is a Seed of $2.2M announced in May 2023.
When did Exazyme last raise funding?
Exazyme's most recent funding round on record is a Seed of $2.2M, announced in May 2023.
Who is the CEO of Exazyme?
Ingmar Schuster is listed as CEO at Exazyme.
Where is Exazyme headquartered?
Exazyme is based in Berlin, Germany.
How many employees does Exazyme have?
Exazyme is in the 1-10 employee band.
How does Exazyme's funding compare to other Biotechnology startups?
Exazyme's latest round of $2.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Exazyme Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Exazyme is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.